United States | EN
Denmark | Dansk
Finland | Suomi
Iceland | íslensku
Poland | Polski
Sweden | Svenska
Improving patient quality of life
With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.
Our growing global organization
As we expand our business globally, we strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options.
To access our corporate contact directories please select from:
Latest Press Releases
October 19, 2026
VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (PhentermineTopiramate MR) to Adolescents with Obesity
October 13, 2026
VIVUS Lowers Cash Price of QSYMIA® to $75 or Less for a 30-Day Supply
April 30, 2026
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
Links and Resources
LOCATIONS
ABOUT VIVUS